Diabetes mellitus, coronary artery disease und heart disease (Update 2019)

被引：2

作者：

Clodi, Martin ^{[1
,2
]}

Saely, Christoph H. ^{[3
]}

Hoppichler, Friedrich ^{[4
]}

Resl, Michael ^{[1
,2
]}

Steinwender, Clemens ^{[5
]}

Stingl, Harald ^{[6
]}

Wascher, Thomas C. ^{[7
]}

Winhofer-Stoeckl, Yvonne ^{[8
]}

Sourij, Harald ^{[9
]}

机构：

[1] Konventhosp Barmherzigen Bruder Linz, Abt Innnere Med, A-4021 Linz, Austria

[2] Johannes Kepler Univ Linz, ICMR, Linz, Austria

[3] Akad Lehrkrankenhaus Feldkirch, Abt Innere Med 1, Feldkirch, Austria

[4] Krankenhaus Barmherzigen Bruder Salzburg, Abt Innere Med, Salzburg, Austria

[5] Kepler Univ Klinikum Linz, Klin Kardiol & Internist Intens Med, Linz, Austria

[6] Landesklinikum Melk, Abt Innere Med, Melk, Austria

[7] Hanusch Hosp, Med Abt 1, Vienna, Austria

[8] Med Univ Wien, Klin Abt Endokrinol & Stoffwechsel, Univ Klin Innere Med 3, Vienna, Austria

[9] Med Univ Graz, Klin Abt Endokrinol & Diabetol, Univ Klin Innere Med, Graz, Austria

来源：

WIENER KLINISCHE WOCHENSCHRIFT | 2019年 / 131卷 / Suppl 1期

关键词：

Diabetes mellitus; Coronary artery disease; Heart failure; Screening; CARDIOVASCULAR RISK-ASSESSMENT; GLYCEMIC CONTROL; TYPE-2; OUTCOMES; EVENTS; FAILURE; METFORMIN; MORTALITY; ATHEROSCLEROSIS; PIOGLITAZONE;

D O I：

10.1007/s00508-019-1488-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with pre-existing diabetes mellitus. In patients with previously diagnosed arterosclerotic cardiovascular disease an agent proven to reduce major adverse cardiovascular events or cardiovascular mortality is recommended after therapy failure of metformin.

引用

页码：169 / 173

页数：5

共 31 条

[1] Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study [J].

Andersson, C. ;

Olesen, J. B. ;

Hansen, P. R. ;

Weeke, P. ;

Norgaard, M. L. ;

Jorgensen, C. H. ;

Lange, T. ;

Abildstrom, S. Z. ;

Schramm, T. K. ;

Vaag, A. ;

Kober, L. ;

Torp-Pedersen, C. ;

Gislason, G. H. .

DIABETOLOGIA, 2010, 53 (12) :2546-2553

[2]

[Anonymous], N ENGL J MED

[3] A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease [J].

Frye R.L. ;

August P. ;

Brooks M.M. ;

Hardison R.M. ;

Kelsey S.F. ;

MacGregor J.M. ;

Orchard T.J. ;

Chaitman B.R. ;

Genuth S.M. ;

Goldberg S.H. ;

Hlatky M.A. ;

Jones T.L.Z. ;

Molitch M.E. ;

Nesto R.W. ;

Sako E.Y. ;

Sobel B.E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (24) :2503-2515

[4] Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient The Imaging Council of the American College of Cardiology [J].

Budoff, Matthew J. ;

Raggi, Paolo ;

Beller, George A. ;

Berman, Daniel S. ;

Druz, Regina S. ;

Malik, Shaista ;

Rigolin, Vera H. ;

Weigold, Wm Guy ;

Soman, Prem .

JACC-CARDIOVASCULAR IMAGING, 2016, 9 (02) :176-192

[5] Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum [J].

Cefalu, William T. ;

Kaul, Sanjay ;

Gerstein, Hertzel C. ;

Holman, Rury R. ;

Zinman, Bernard ;

Skyler, Jay S. ;

Green, Jennifer B. ;

Buse, John B. ;

Inzucchi, Silvio E. ;

Leiter, Lawrence A. ;

Raz, Itamar ;

Rosenstock, Julio ;

Riddle, Matthew C. .

DIABETES CARE, 2018, 41 (01) :14-31

[6] Prognostic Significance of Silent Myocardial Infarction in Newly Diagnosed Type 2 Diabetes Mellitus United Kingdom Prospective Diabetes Study (UKPDS) 79 [J].

Davis, Timothy M. E. ;

Coleman, Ruth L. ;

Holman, Rury R. .

CIRCULATION, 2013, 127 (09) :980-+

[7] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[8] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes [J].

Duckworth, William ;

Abraira, Carlos ;

Moritz, Thomas ;

Reda, Domenic ;

Emanuele, Nicholas ;

Reaven, Peter D. ;

Zieve, Franklin J. ;

Marks, Jennifer ;

Davis, Stephen N. ;

Hayward, Rodney ;

Warren, Stuart R. ;

Goldman, Steven ;

McCarren, Madeline ;

Vitek, Mary Ellen ;

Henderson, William G. ;

Huang, Grant D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) :129-U62

[9] Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus [J].

Evans, Josie M. M. ;

Doney, Alex S. F. ;

AlZadjali, Matlooba A. ;

Ogston, Simon A. ;

Petrie, John R. ;

Morris, Andrew D. ;

Struthers, Allan D. ;

Wong, Aaron K. F. ;

Lang, Chim C. .

AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07) :1006-1010

[10]

Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743

← 1 2 3 4 →